Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $76.53 ($1.9M) on 2019-02-27, disclosed to the SEC on 2019-03-01.
Open-market sale of $1.9M GHDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.53 | 22,807 | $1.7M | 91.1% |
| 2 | $77.29 | 2,193 | $169K | 8.9% |
| Total | $76.60 avg | 25,000 | $1.9M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $1.3M | — | Filing → |